ERBB2 and breast cancer: When the HER2‐driven morphometric features were combined with ER and PR status (clinico‐morphometric prognostic index) this achieved the highest accuracy in prediction of the risk of early recurrence in HER2‐positive BC patients with c‐index = 0.81, AUC = 0.87 in the test cohort.